Impact BioMedical Statistics Share Statistics Impact BioMedical has 12.09M
shares outstanding. The number of shares has increased by 5.11%
in one year.
Shares Outstanding 12.09M Shares Change (YoY) 5.11% Shares Change (QoQ) -39.87% Owned by Institutions (%) 0.18% Shares Floating 11.98M Failed to Deliver (FTD) Shares 21,658 FTD / Avg. Volume 0.27%
Short Selling Information The latest short interest is 308.22K, so 2.55% of the outstanding
shares have been sold short.
Short Interest 308.22K Short % of Shares Out 2.55% Short % of Float 4.6% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -164.33 and the forward
PE ratio is null.
Impact BioMedical's PEG ratio is
0.
PE Ratio -164.33 Forward PE n/a PS Ratio 144.63 Forward PS n/a PB Ratio 79.16 P/FCF Ratio -86.02 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Impact BioMedical.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 0.25,
with a Debt / Equity ratio of 2.08.
Current Ratio 0.25 Quick Ratio 0.25 Debt / Equity 2.08 Debt / EBITDA -5.77 Debt / FCF -2.27 Interest Coverage 3.27
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $1.17M Profits Per Employee $-1.03M Employee Count 2 Asset Turnover 0.11 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -99.86% in the
last 52 weeks. The beta is 6.78, so Impact BioMedical's
price volatility has been higher than the market average.
Beta 6.78 52-Week Price Change -99.86% 50-Day Moving Average 0.63 200-Day Moving Average 1.34 Relative Strength Index (RSI) 44.01 Average Volume (20 Days) 7,935,909
Income Statement In the last 12 months, Impact BioMedical had revenue of 2.33M
and earned -2.05M
in profits. Earnings per share was -0.01.
Revenue 2.33M Gross Profit 2.33M Operating Income 551.66K Net Income -2.05M EBITDA -1.54M EBIT -1.88M Earnings Per Share (EPS) -0.01
Full Income Statement Balance Sheet The company has 2M in cash and 8.88M in
debt, giving a net cash position of -6.88M.
Cash & Cash Equivalents 2M Total Debt 8.88M Net Cash -6.88M Retained Earnings -37.67M Total Assets 20.05M Working Capital -7.79M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -3.92M
and capital expenditures 0, giving a free cash flow of -3.92M.
Operating Cash Flow -3.92M Capital Expenditures n/a Free Cash Flow -3.92M FCF Per Share -0.02
Full Cash Flow Statement Margins Gross margin is 100%, with operating and profit margins of 23.67% and -88.01%.
Gross Margin 100% Operating Margin 23.67% Pretax Margin -88.01% Profit Margin -88.01% EBITDA Margin -66.03% EBIT Margin 23.67% FCF Margin -168.12%
